Empowering Science, Research & Education
Kiran Mazumdar-Shaw’s recognition highlights her vision of leveraging science and innovation to create sustainable social impact and drive equitable access to opportunities for communities in India and beyond.
Kiran Mazumdar-Shaw, Founder & Chairperson, Biocon Group said, “I am deeply honored to be featured on the EdelGive Hurun India Philanthropy List 2025. For me, philanthropy has never been about the magnitude of giving, but about giving with a purpose, a purpose to create lasting impact and make a meaningful difference in people’s lives and in society. I have always believed that investing in science, research, and innovation can unlock transformative solutions for humanity. Through my philanthropic initiatives, I remain committed to nurturing ideas and institutions that can change the world for the better and help build a more equitable and inclusive future.”
EdelGive Hurun India Philanthropy List 2025 highlighted, “Kiran Mazumdar-Shaw, 72, ranks second among women philanthropists, donating INR 83 Cr, primarily supporting science, research, and education. As the founder and chairperson of Biocon, she is dedicated to enhancing healthcare access and advancing medical research. Through Mazumdar Shaw Philanthropy (MSP), she is committed to building critical mass at leading Indian and global academic, arts, and social institutions. In doing this, she hopes to create and support research ecosystems for breakthrough ideas and transformative global impact. MSP is focused on exploring the frontiers of scientific discovery, nurturing artistic expression, honoring India’s culture and heritage, and bringing communities together.”
The Pharma industry has the largest number of philanthropists in the list, accounting for 16%, followed by Software & Services, Automobile & Auto Components and Chemicals & Petrochemicals at eight percent each.
Mazumdar Shaw Philanthropy : Impact Research; Advance Humanity
Kiran Mazumdar-Shaw’s philosophy of philanthropy is deeply rooted in the belief that giving must create sustainable and transformative impact. Together with her late husband, John Shaw, she has dedicated her philanthropic efforts to advancing scientific discovery, nurturing artistic expression, honoring India’s cultural heritage, and fostering community development. Her giving is driven by a strong purpose, to make a meaningful difference in global healthcare, particularly in the developing world. Through her initiatives, she strives to empower scientists and research-driven clinicians to pursue innovations that integrate therapeutic and diagnostic breakthroughs. Kiran envisions a world where these advancements not only improve patient outcomes but also make quality healthcare more affordable and accessible for all.
The EdelGive Foundation, the philanthropic arm of the Edelweiss Group, in partnership with the Hurun Report, unveiled the 12th edition of the EdelGive Hurun India Philanthropy List. The annual report highlights individuals who have donated INR 5 crore or more during the review period.
About Hurun India
Hurun India, launched in 2012, celebrates India’s stories of transparent wealth creation, innovation, and social impact across five core pillars — Value Creation by Companies, Wealth Creation, Startups, Philanthropy, and Culture India.
Methodology: EdelGive Hurun Philanthropy List
To curate the list, Hurun Report surveyed India’s most successful entrepreneurs, including those featured in the Hurun India Rich List 2025, and cross-referenced data with media reports and charitable foundations.
About Biocon Group
As a global frontrunner in the biopharmaceuticals industry, the Biocon Group is steadfast in its commitment to enable health equity worldwide by providing patients across the world with affordable access to essential and lifesaving therapeutics. Through its key business verticals of Generics, Biosimilars, and CRDMO, the Biocon Group has harnessed its affordable innovation model to develop and manufacture both small and large molecules on a global scale, ultimately benefiting patients worldwide. Together, we are bringing impactful and inclusive healthcare solutions for those who need them the most.
